Research graph
References from Younger Age Is Associated With Slower PSA Decline After Low‐Dose‐Rate Brachytherapy for Localized Prostate Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
A Biochemical Definition of Cure After Brachytherapy for Prostate Cancer
10.1016/j.radonc.2020.04.038 · 2020 · External reference
Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4‐Year Prostate‐Specific Antigen Nadir as a Predictor of 10‐ and 15‐Year Disease‐Free Survival
10.1016/j.clon.2021.11.009 · 2022 · External reference
Prostate‐Specific Antigen (PSA) Nadir and Experience of PSA Bounce After Low‐Dose‐Rate Brachytherapy for Prostate Cancer Predicts Clinical Failure
10.1016/j.brachy.2024.09.003 · 2024 · External reference
PSA Bounce and Biochemical Failure After Brachytherapy for Prostate Cancer: A Study of 820 Patients With a Minimum of 3 Years of Follow‐Up
10.1016/j.ijrobp.2010.02.021 · 2011 · External reference
Patient Age as a Predictive Factor in Biochemical Recurrence Following Brachytherapy: Oncological Outcomes at a Single Center
10.1016/j.prnil.2022.05.003 · 2022 · External reference
Biochemical Outcomes and Toxicities in Young Men With Prostate Cancer After Permanent Iodine‐125 Seed Implantation: Prospective Cohort Study in 6662 Patients
2023 · External reference
Evaluating Local Doses for Prostate Cancer Treatment Using Low‐Dose‐Rate Brachytherapy Considering Oncological Control and Toxicity
10.1002/pros.70039 · 2025 · External reference
10.1186/1471‐2490‐12‐28
10.1186/1471‐2490‐12‐28 · External reference
10.1186/1748‐717x‐8‐25
10.1186/1748‐717x‐8‐25 · External reference
Defining Biochemical Failure Following Radiotherapy With or Without Hormonal Therapy in Men With Clinically Localized Prostate Cancer: Recommendations of the RTOG‐ASTRO Phoenix Consensus Conference
10.1016/j.ijrobp.2006.04.029 · 2006 · External reference
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine‐125 Seed Implantation (J‐POPS): First Analysis on Survival
10.1007/s10147-018-1309-0 · 2018 · External reference
10.1016/j.ijrobp.2009.07.1724
10.1016/j.ijrobp.2009.07.1724 · External reference
10.3390/cancers17172867
10.3390/cancers17172867 · External reference
Investigation of the Freely Available Easy‐To‐Use Software ‘EZR’ for Medical Statistics
10.1038/bmt.2012.244 · 2013 · External reference
Impact of Age on Treatment Response in Men With Prostate Cancer Treated With Radiotherapy
10.1002/bco2.132 · 2021 · External reference
Prostate‐Specific Antigen Bounce After 125I‐Brachytherapy for Prostate Cancer Is a Favorable Prognosticator in Patients Who Are Biochemical Recurrence‐Free at 4 Years and Correlates With Testosterone
10.1093/jjco/hyz136 · 2020 · External reference
Circulating Total Testosterone and PSA Concentrations in a Nationally Representative Sample of Men Without a Diagnosis of Prostate Cancer
10.1002/pros.22998 · 2015 · External reference
Tumour and Immune Cell Dynamics Explain the PSA Bounce After Prostate Cancer Brachytherapy
10.1038/bjc.2016.171 · 2016 · External reference
Relationship Between Sexual Function and Prostate‐Specific Antigen Bounce After Iodine‐125 Permanent Implant Brachytherapy for Localized Prostate Cancer
10.1111/iju.12411 · 2014 · External reference
